Downregulated parafibromin expression is a promising marker for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas
Authors:
Open Access
- 14 December 2007
- journal article
- research article
- Published by Springer Nature in Virchows Archiv
- Vol. 452 (2) , 147-155
Abstract
Parafibromin is a protein encoded by the hyperparathyroidism 2 oncosuppressor gene and its downregulated expression is involved in pathogenesis of parathyroid carcinomas. To clarify the roles of parafibromin expression in tumourigenesis and progression of gastric carcinomas, it was examined by immunohistochemistry (IHC) on tissue microarray containing gastric carcinomas (n = 508), adenomas (n = 45) and gastritis (n = 49) with a comparison of its expression with clinicopathological parametres of carcinomas. Gastric carcinoma cell lines (MKN28, AGS, MKN45, KATO-III and HGC-27) were studied for parafibromin expression by IHC and western blot. Parafibromin expression was localised in the nucleus of gastric epithelial cells, adenoma, carcinoma cells and cell lines. Its expression was gradually decreased from gastritis to gastric carcinoma, through gastric adenomas (p < 0.05) and inversely correlated with tumour size, depth of invasion, lymphatic invasion, lymph node metastasis and Union Internationale Contre le Cancer (UICC) staging (p < 0.05) but not with sex or venous invasion (p > 0.05). Parafibromin was strongly expressed in older carcinoma patients compared with younger ones (p < 0.05). There was stronger positivity of parafibromin in intestinal-type than diffuse-type carcinomas (p < 0.05). Univariate analysis indicated cumulative survival rate of patients with positive parafibromin expression to be higher than without its expression (p < 0.05). Multivariate analysis showed that age, tumour size, depth of invasion, lymphatic invasion, lymph node metastasis, UICC staging and Lauren’s classification but not sex, venous invasion or parafibromin expression were independent prognostic factors for carcinomas(p < 0.05). Downregulated parafibromin expression possibly contributed to pathogenesis, growth, invasion and metastasis of gastric carcinomas. It was considered as a promising marker to indicate the aggressive behaviours and prognosis of gastric carcinomas.Keywords
This publication has 33 references indexed in Scilit:
- The Parafibromin Tumor Suppressor Protein Is Part of a Human Paf1 ComplexMolecular and Cellular Biology, 2005
- Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expressionOncogene, 2004
- Loss of Parafibromin Immunoreactivity Is a Distinguishing Feature of Parathyroid CarcinomaClinical Cancer Research, 2004
- Improved 1-h rapid immunostaining method using intermittent microwave irradiation: practicability based on 5 years application in Toyama Medical and Pharmaceutical University HospitalLaboratory Investigation, 2004
- Somatic and Germ-Line Mutations of theHRPT2Gene in Sporadic Parathyroid CarcinomaNew England Journal of Medicine, 2003
- Role of PTEN and MMP‐7 expression in growth, invasion, metastasis and angiogenesis of gastric carcinomaPathology International, 2003
- HRPT2 mutations are associated with malignancy in sporadic parathyroid tumoursJournal of Medical Genetics, 2003
- Geographic pathology on the precursors of stomach cancer.1992
- [Gastric carcinoma in its early stages].1967
- THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO‐CALLED INTESTINAL‐TYPE CARCINOMAActa Pathologica Microbiologica Scandinavica, 1965